Experimental: CHF6001 3200 μg
CLI-06001AA2-01
Phase 2 small_molecule terminated
Quick answer
Experimental: CHF6001 3200 μg for Uncontrolled Asthma is a Phase 2 program (small_molecule) at Chiesi Farmaceutici S.p.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Chiesi Farmaceutici S.p.A.
- Indication
- Uncontrolled Asthma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated